QUMAS (www.qumas.com), compañía especializada en soluciones de gestión documental y compliance, ha anunciado que Amneal Pharmaceuticals, fabricante de medicinas en Estados Unidos, ha desplegado la solución QUMAS DocCompliance y ProcessCompliance para gestionar toda la calidad de sus documentos en sus instalaciones de la unión americana y la India. Más abajo el resto de la noticia en inglés.
These QUMAS software solutions deliver comprehensive capabilities around document management (SOPs, methods, procedures, etc.) and process management (CAPAs, deviations, customer issues, etc.), presenting all activities through MyQUMAS, a web-based user interface, with consolidated reporting and dashboarding, all driving regulatory compliance, quality assurance and ultimately delivering better business performance.
«The initial deployment went smoothly,» stated David Miller, Vice President of Quality for Amneal Pharmaceuticals. «Now that we are up and running in the quality departments at all of our sites we are currently making plans to roll out the QUMAS platform to additional departments in the company.»
«This engagement with Amneal reinforces our position as the leading provider of regulatory compliance and quality solutions to the life sciences industry,» said Kevin O’Leary, CEO for QUMAS. «We have a large generic pharmaceutical manufacturer client base globally, and continue to see this area of the life sciences sector grow in strength».